Baricitinib alleviates lipopolysaccharide‑induced human periodontal ligament stem cell injury and promotes osteogenic differentiation by inhibiting JAK/STAT signaling

Periodontitis is the chronic inflammation of the periodontal tissue. The present study aimed to investigate the role of baricitinib, a Janus kinase (JAK)1/2 inhibitor, in periodontitis by using a lipopolysaccharide (LPS)-induced human periodontal ligament stem cell (PDLSC) model. The viability of PD...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ping, Shi, Fenghua, Zhang, Yanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842944/
https://www.ncbi.nlm.nih.gov/pubmed/36684656
http://dx.doi.org/10.3892/etm.2022.11773

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842944/
https://www.ncbi.nlm.nih.gov/pubmed/36684656
http://dx.doi.org/10.3892/etm.2022.11773

Ejemplares similares